Trikafta

(elexacaftor / ivacaftor / tezacaftor)
NO BOXED WARNING

Dosage & administration

Recommended Dosage for Adult and Pediatric Patients aged 6 Years and Older
AgeMorning DoseEvening Dose
6 to less than 12 years weighing less than 30 kgsTwo tablets, each containing elexacaftor 50 mg/tezacaftor 25 mg/ivacaftor 37.5 mgOne tablet of ivacaftor 75 mg
6 to less than 12 years weighing 30 kgs or moreTwo tablets, each containing elexacaftor 100 mg/tezacaftor 50 mg/ivacaftor 75 mgOne tablet of ivacaftor 150 mg
12 years and olderTwo tablets, each containing elexacaftor 100 mg/tezacaftor 50 mg/ivacaftor 75 mgOne tablet of ivacaftor 150 mg

drug label

Trikafta prescribing information

financial assistance

Trikafta financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
Vertex GPS Patient Enrollment Form
Vertex GPS Patient Enrollment Form - Spanish
Vertex GPS Patient Enrollment Form - Online
Learn More

PubMedâ„¢ | Trikafta

Trikafta PubMedâ„¢ News

people also ask

Trikafta FAQs

How is the dosage of Trikafta? is available in 2 dosages, including mixed Pack and mixed Pack
What does Trikafta treat? treats Cystic Fibrosis
What is Trikafta made of? contains elexacaftor / ivacaftor / tezacaftor which is a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
How Is Trikafta Administered? is administered as a Pack
What Are The Trikafta Mechanism Of Action? mechanism of action is Chloride Channel Activation Potentiators, Cytochrome P450 2C9 Inhibitors, Cytochrome P450 3A Inhibitors, Cytochrome P450 3A4 Inhibitors or P-Glycoprotein Inhibitors
FAQ Data Source